Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,252
  • Shares Outstanding, K 10,991
  • Annual Sales, $ 602,460 K
  • Annual Income, $ 2,090 K
  • EBIT $ -6 M
  • EBITDA $ 6 M
  • 60-Month Beta 0.53
  • Price/Sales 0.28
  • Price/Cash Flow 3.85
  • Price/Book 0.58

Options Overview Details

View History
  • Implied Volatility 51.64% (-2.11%)
  • Historical Volatility 38.45%
  • IV Percentile 51%
  • IV Rank 18.17%
  • IV High 116.89% on 01/07/26
  • IV Low 37.15% on 05/09/25
  • Expected Move (DTE 8) 1.36 (12.53%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 16
  • Volume Avg (30-Day) 159
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 21,600
  • Open Int (30-Day) 20,601
  • Expected Range 9.49 to 12.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.76
  • Number of Estimates 1
  • High Estimate -0.76
  • Low Estimate -0.76
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -860.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.80 +0.46%
on 02/11/26
12.14 -10.63%
on 01/26/26
-0.57 (-4.99%)
since 01/09/26
3-Month
10.10 +7.43%
on 01/05/26
12.47 -12.99%
on 12/12/25
-0.80 (-6.87%)
since 11/11/25
52-Week
10.10 +7.43%
on 01/05/26
16.66 -34.89%
on 02/14/25
-4.28 (-28.29%)
since 02/11/25

Most Recent Stories

More News
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31,...

MED : 10.85 (-2.60%)
3 Stocks Under $50 We Approach with Caution

3 Stocks Under $50 We Approach with Caution

WASH : 35.76 (-1.30%)
IART : 11.18 (+1.82%)
MED : 10.85 (-2.60%)
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

GDRX : 2.23 (-4.29%)
BLBD : 57.77 (+1.82%)
MED : 10.85 (-2.60%)
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

STRA : 77.27 (-4.16%)
SNBR : 10.24 (-4.21%)
MED : 10.85 (-2.60%)
People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®

A Powerful Story of Improving Metabolic Health Through Science, Coaching and Community

MED : 10.85 (-2.60%)
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity

Thousands of Independent Coaches Gather Nationwide to Discuss Solutions to America’s Metabolic Health Crisis

MED : 10.85 (-2.60%)
3 Reasons to Avoid MED and 1 Stock to Buy Instead

3 Reasons to Avoid MED and 1 Stock to Buy Instead

MED : 10.85 (-2.60%)
Medifast Announces Planned Leadership Transition

  Nicholas Johnson Appointed President, and Expected to Succeed Dan Chard as CEO in June 2026; Chard to Remain Chairman

MED : 10.85 (-2.60%)
1 Consumer Stock to Target This Week and 2 We Question

1 Consumer Stock to Target This Week and 2 We Question

CALM : 83.18 (+1.90%)
BF.B : 30.28 (+1.24%)
MED : 10.85 (-2.60%)
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

MED : 10.85 (-2.60%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 11.42
2nd Resistance Point 11.29
1st Resistance Point 11.07
Last Price 10.85
1st Support Level 10.72
2nd Support Level 10.58
3rd Support Level 10.36

See More

52-Week High 16.66
Fibonacci 61.8% 14.16
Fibonacci 50% 13.38
Fibonacci 38.2% 12.61
Last Price 10.85
52-Week Low 10.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar